Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry

Thomas J Knobloch1, Lana K Uhrig2, Dennis K Pearl3

  • 1The Ohio State University, Columbus, Ohio. Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. Division of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, Ohio. knobloch.1@osu.edu.

Insights

Black raspberries (BRB) deliver cancer-fighting compounds to oral tissues, reducing key gene markers linked to oral cancer development. This study confirms BRB

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Black raspberries (BRB) show promise in preventing aerodigestive tract cancers in animal models.
  • Translational research on BRB phytochemicals in oral mucosa is limited.
  • Oral cancer prevention strategies require understanding phytochemical delivery and molecular impact.

Purpose of the Study:

  • To determine if BRB phytochemicals reach oral tissues.
  • To assess the effect of BRB on proinflammatory and antiapoptotic gene expression in oral cancer.
  • To identify potential molecular biomarkers for BRB-mediated chemoprevention.

Main Methods:

  • Phase 0 clinical trial involving patients with oral squamous cell carcinoma (OSCC).
  • Administration of oral troches containing freeze-dried BRB powder before surgery.
  • Evaluation of gene expression in matched OSCC and high at-risk mucosa (HARM) tissues.
  • Detection of specific BRB phytochemicals in tumor tissues.

Main Results:

  • BRB phytochemicals (cyanidin-3-rutinoside, cyanidin-3-xylosylrutinoside) were detected in all analyzed OSCC tissues.
  • Significant reduction in prosurvival (AURKA, BIRC5, EGFR) and proinflammatory (NFKB1, PTGS2) gene expression post-BRB administration.
  • No significant toxicities or adverse events reported; high patient compliance.
  • Confirmed overexpression of antiapoptotic and proinflammatory biomarkers in OSCC, reduced by BRB.

Conclusions:

  • BRB phytochemicals successfully reach targeted oral cancer tissues.
  • BRB administration modulates key molecular pathways involved in oral carcinogenesis.
  • Modifiable molecular biomarkers show potential for assessing BRB efficacy in oral cancer chemoprevention.